Ensysce Biosciences, Inc. (ENSC) Shareholder/Analyst Call Prepared Remarks Transcript

Operator

Greetings. Welcome to the 2025 Annual Meeting of Stockholders of Ensysce Biosciences, Inc. [Operator Instructions] Please note that this conference is being recorded. [Operator Instructions] I will now turn the conference over to your host, Dr. Bob Gower, Chairman of the Board. Please go ahead.

Robert Gower

Good morning, ladies and gentlemen, and thank you for joining the Ensysce Biosciences 2025 Virtual Annual Meeting of stockholders that was adjourned from December 23, 2025, to today. I am Bob Gower and I have served as Chairman of the Board since 2008. We’ve continued the virtual format for our annual meeting to help promote safety while providing a consistent experience to all stockholders regardless of your location. I am pleased to be presiding over today’s meeting.

Also joining us today virtually are the members of our Board of Directors, and it’s my pleasure to introduce each of them now. William Chang. William joined the Board in 2016 and serves on our Compensation Committee. Bob Gower. I joined the Board in 2008, and I’m a member of our Nominating Committee and Nominating and Corporate Governance Committee, and I also serve on the Audit Committee and Compensation Committee. Lynn Kirkpatrick. Lynn joined our board in 2009 and has served since that time as our Chief Executive Officer. Adam S. Levin, MD. Adam joined the Board in 2021 and chairs our Compensation Committee. Steve R. Martin. Steve joined the Board in 2020 and Chairs the Audit Committee. He also serves on our Nominating and Corporate Governance Committee. Lee Rusch. Lee joined the Board in 2022 and serves on our Audit Committee and Compensation Committee and as Chairperson of our Nominating and Corporate Governance Committee. Curtis Rosebraugh. Curtis joined the Board in 2021. Curtis serves on